Tyrogenex X-82 Poster Presentation at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Tyrogenex, a leader in the development of novel kinase inhibitors to target angiogenesis, announced that the University of Wisconsin presented a new trial concept of X-82 poster at ASCO in Chicago.
